Golden State Warriors superstar point guard Stephen Curry has only played in two games in the 2016 NBA playoffs due to an ankle injury and a Grade 1 MCL sprain in his right knee. According to the latest Warriors news, Curry underwent platelet-rich plasma (PRP) treatment on his knee and is probable for Game 3 against the Portland Trail Blazers.
The Warriors are 4-1 in the postseason without Curry, who suffered a right knee sprain in Game 4 of the first-round series versus the Houston Rockets. An MRI test revealed a Grade 1 MCL sprain and he was ruled out for two weeks.
Related Warriors News: Stephen Curry to sit out at least two weeks with MCL sprain
However, Curry confirmed via Diamond Leung of the Bay Area News Group that he underwent PRP treatment to speed up his recovery. He is reportedly nearing a return to basketball activities in just nine days after the injury.
According to a report by Yahoo! Sports, PRP treatment was popularized by Kobe Bryant, who flew to Germany to get his arthritic right knee healed. Other stars that underwent the procedure include Pau Gasol, Dwight Howard, Wesley Matthews, Brandon Roy, Dwyane Wade and Deron Williams.
Curry’s Warriors teammate, Andrew Bogut, also underwent PRP therapy in 2014. However, there are still many skeptics on the use of PRP to quickly heal up an injury.
Related Warriors News: Stephen Curry is confident of returning in game 3 against Blazers
Nonetheless, Golden State is still unsure whether the reigning MVP will be available on May 7, Saturday for Game 3 in Portland. The Warriors are looking to take a 3-0 series lead and increase their chances to advance to the Western Conference Finals for the second-straight year.
“He’s doing pretty well, going through the rehab process, and he’s making the improvement that we’re looking for. It’s really more about what the training staff tells us about being at risk for further injury. If he’s not at risk, and he’s at 80, 90 percent, he’ll play,” Warriors head coach Steve Kerr told the San Francisco Chronicle.
Photo Courtesy: Noah Salzman/Wikimedia